COMMUNIQUÉS West-GlobeNewswire

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats
09/05/2024
First veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non [...]
Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights
09/05/2024
First quarter revenue of $13.2M, +27% year-over-year growth; IFRS gross margin of 75.2% First quarter pulse recurring revenue of $4.7M, +118% year-over-year growth IFRS and non-IFRS operating loss narrowed to -$1.0M and [...]
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
09/05/2024
Pre-treatment Sample of Patient’s Blood Showed Rapid and Potent Depletion of CD19+ B Cells in Ex Vivo Cytotoxicity Assay with FT819 Translational Data from FT819 Phase 1 B Cell Malignancies Study Support Key Therapeutic [...]
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
09/05/2024
ZUG, Switzerland and BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced [...]
Selectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in Georgia
09/05/2024
- Archway Nursing Facility and Related Property to be Sold for $6.75 Million - Greenwood Village, Colorado, May 09, 2024 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") announced that [...]
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
09/05/2024
HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on May 23, 2024, at 4:15 p.m. ET. The exclusive event, [...]
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
09/05/2024
FDA clearance to recruit teens in both on-going Netherton Syndrome clinical studies U.S. and International patent filed for novel Netherton Syndrome combination product Cash runway extended into late 2025 ASHBURN, Va., [...]
Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care
09/05/2024
Following Nuvo’s NASDAQ Listing, Addition of Machado Brings Strong Health and Impact Experience to Remote Pregnancy Monitoring Pioneer TEL AVIV, Israel, May 09, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd (NASDAQ [...]
Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations
09/05/2024
Company Implementing Next Phase of Its Recombinant Spider Silk Business Plan ANN ARBOR, Mich., May 09, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces [...]
Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s
09/05/2024
Fitness Now a Key Component of Noom's Whole-Person Health Solution For All Members NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and [...]
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
09/05/2024
Completed enrollment in izokibep Phase 3 trial in hidradenitis suppurativa and enrollment completion in Phase 2b/3 trial in uveitis expected this month; top line data for both trials now expected by end of third and [...]
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
09/05/2024
WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and [...]
ORYZON to Provide Corporate Progress Updates at Several Events in May
09/05/2024
Bio-Equity Europe 2024 Asebio Investor Day 2024 RSC Hot Topics: Covalent Drug Discovery Foro Medcap BME 2024 MADRID, Spain and CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: [...]
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
09/05/2024
- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase [...]
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
09/05/2024
Leveraging Akoya’s market-leading PhenoImager HT platform and clinical development expertise with NeraCare’s Immunoprint test and best-in-class clinical data, the partnership will focus on increasing access to life [...]
Dental Influencers Alliance Attendees Praise Halo Dental Technologies’ Digital Mirror at Annual Get Together
09/05/2024
Waitlist for first-of-its-kind digital dental mirror announced, opening May 2024 for dentists and hygienists who want to be among the first to secure the Halo Digital Mirror. MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- [...]
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
09/05/2024
SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
Annexon Biosciences to Present at the Bank of America Health Care Conference
09/05/2024
BRISBANE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]
Stryker declares a $0.80 per share quarterly dividend
09/05/2024
Portage, Michigan, May 09, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable July 31, 2024 to shareholders of record at the [...]

Pages